Persistence and reappearance of high-risk human papillomavirus after conization

Gynecologic Oncology

Volumn 131, Issue 3, 2013, Pages 661-666

  Gosvig, Camilla Flarup ^a   Huusom, Lene Drasbek ^a   Andersen, Klaus Kaae ^a   Iftner, Angelika ^c   Cederkvist, Luise ^a   Svare, Edith ^b   Iftner, Thomas ^c   Kjaer, Susanne Krüger ^a,d  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^b Private Gynaecological Clinic   (Denmark)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^d University of Copenhagen   (Denmark)

Author keywords

Conization; HPV DNA viral load; HPV persistence; HPV reappearance

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; CANCER GRADING; CANCER SURGERY; COHORT ANALYSIS; DISEASE SEVERITY; FEMALE; FOLLOW UP; GENOTYPING TECHNIQUE; HIGH RISK PATIENT; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; ORAL CONTRACEPTIVE USE; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; REINFECTION; RISK ASSESSMENT; SMOKING; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CONIZATION; UTERINE CERVIX CYTOLOGY; VERRUCA VULGARIS; VIRUS LOAD; WART VIRUS;

CONIZATION; HPV DNA VIRAL LOAD; HPV PERSISTENCE; HPV REAPPEARANCE;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; COHORT STUDIES; CONIZATION; DNA, VIRAL; FEMALE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROSPECTIVE STUDIES; RISK FACTORS; UTERINE CERVICAL NEOPLASMS; VIRAL LOAD;

EID: 84888301301     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2013.09.002     Document Type: Article

References (37)

1. J. Ferlay, H.R. Shin, F. Bray, D. Forman, C. Mathers, and D.M. Parkin Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int J Cancer 127 Jun 17 2010 2893 2917
2. J. Melnikow, C. McGahan, G.F. Sawaya, T. Ehlen, and A. Coldman Cervical intraepithelial neoplasia outcomes after treatment: long-term follow-up from the British Columbia Cohort Study J Natl Cancer Inst 101 10 May 20 2009 721 728
3. M. Kocken, T.J. Helmerhorst, J. Berkhof, J.A. Louwers, M.A. Nobbenhuis, and A.G. Bais Risk of recurrent high-grade cervical intraepithelial neoplasia after successful treatment: a long-term multi-cohort study Lancet Oncol 12 5 May 2011 441 450
4. Y.T. Kim, J.M. Lee, S.Y. Hur, C.H. Cho, Y.T. Kim, and S.C. Kim Clearance of human papillomavirus infection after successful conization in patients with cervical intraepithelial neoplasia Int J Cancer 126 8 Apr 15 2010 1903 1909
5. W.D. Kang, M.J. Oh, S.M. Kim, J.H. Nam, C.S. Park, and H.S. Choi Significance of human papillomavirus genotyping with high-grade cervical intraepithelial neoplasia treated by a loop electrosurgical excision procedure Am J Obstet Gynecol 203 1 Jul 2010 72 76
6. J. Jones, A. Saleem, N. Rai, T.S. Shylasree, S. Ashman, and K. Gregory Human papillomavirus genotype testing combined with cytology as a 'test of cure' post treatment: the importance of a persistent viral infection J Clin Virol 52 2 Oct 2011 88 92
7. A. Lubrano, N. Medina, V. Benito, O. Arencibia, J.M. Falcon, and L. Leon Follow-up after LLETZ: a study of 682 cases of CIN 2-CIN 3 in a single institution Eur J Obstet Gynecol Reprod Biol 161 1 Mar 2012 71 74
8. K. Nam, S. Chung, J. Kim, S. Jeon, and D. Bae Factors associated with HPV persistence after conization in patients with negative margins J Gynecol Oncol 20 2 Jun 2009 91 95
9. S.H. Song, J.K. Lee, M.J. Oh, J.Y. Hur, J.Y. Na, and Y.K. Park Persistent HPV infection after conization in patients with negative margins Gynecol Oncol 101 3 Jun 2006 418 422
10. H.Y. Guo, Y.L. Guo, K. You, and L. Geng Twelve-month follow-up detection of high-risk human papillomavirus (HPV) DNA for 93 cases with cervical intraepithelial neoplasia grade 2 or 3 (CIN 2-3) after a loop electrosurgical excisional procedure (LEEP) Eur J Gynaecol Oncol 32 2 2011 164 167
11. L.O. Sarian, S.F. Derchain, D.R. Pitta, S.S. Morais, and S.H. Rabelo-Santos Factors associated with HPV persistence after treatment for high-grade cervical intra-epithelial neoplasia with large loop excision of the transformation zone (LLETZ) J Clin Virol 31 4 Dec 2004 270 274
12. J.Y. Park, K.H. Lee, S.M. Dong, S. Kang, S.Y. Park, and S.S. Seo The association of pre-conization high-risk HPV load and the persistence of HPV infection and persistence/recurrence of cervical intraepithelial neoplasia after conization Gynecol Oncol 108 3 Mar 2008 549 554
13. A. Aerssens, P. Claeys, E. Beerens, A. Garcia, S. Weyers, and R.L. Van Prediction of recurrent disease by cytology and HPV testing after treatment of cervical intraepithelial neoplasia Cytopathology 20 1 Feb 2009 27 35
14. E. Kucera, G. Sliutz, K. Czerwenka, G. Breitenecker, S. Leodolter, and A. Reinthaller Is high-risk human papillomavirus infection associated with cervical intraepithelial neoplasia eliminated after conization by large-loop excision of the transformation zone? Eur J Obstet Gynecol Reprod Biol 100 1 Dec 10 2001 72 76
15. A.R. Kreimer, H.A. Katki, M. Schiffman, C.M. Wheeler, and P.E. Castle Viral determinants of human papillomavirus persistence following loop electrical excision procedure treatment for cervical intraepithelial neoplasia grade 2 or 3 Cancer Epidemiol Biomarkers Prev 16 1 Jan 2007 11 16
16. K. Syrjanen Persistent high-risk human papillomavirus (HPV) infections as surrogate endpoints of progressive cervical disease. Potential new endpoint for efficacy studies with new-generation (non-HPV 16/18) prophylactic HPV vaccines Eur J Gynaecol Oncol 32 1 2011 17 33
17. F. Broccolo, L. Fusetti, and L. Ceccherini-Nelli Is it true that pre-conization high-risk HPV DNA load is a significant factor of persistence of HPV infection after conization? J Clin Virol 55 4 Dec 2012 377 378
18. S.K. Kjaer, K. Frederiksen, C. Munk, and T. Iftner Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence J Natl Cancer Inst 102 19 Oct 6 2010 1478 1488
19. A. Nielsen, S.K. Kjaer, C. Munk, M. Osler, and T. Iftner Persistence of high-risk human papillomavirus infection in a population-based cohort of Danish women J Med Virol 82 4 Apr 2010 616 623
20. M. Schiffman, R. Herrero, R. Desalle, A. Hildesheim, S. Wacholder, and A.C. Rodriguez The carcinogenicity of human papillomavirus types reflects viral evolution Virology 337 1 Jun 20 2005 76 84
21. U.S.Department of Health & Human Services. FDA U.S. Food and Drug Administration. 2013.Ref Type: Data File
22. N. Munoz, F.X. Bosch, Herrero R. de SS, X. Castellsague, and K.V. Shah Epidemiologic classification of human papillomavirus types associated with cervical cancer N Engl J Med 348 6 Feb 6 2003 518 527
23. R Development Core Team R Foundation for Statistical Computing VA. A Language and Environment for Statistical Computing 2008 [Ref Type: Data File]
24. T. Iftner, L. Germ, R. Swoyer, S.K. Kjaer, J.G. Breugelmans, and C. Munk Study comparing human papillomavirus (HPV) real-time multiplex PCR and hybrid capture II INNO-LiPA v2 HPV genotyping PCR assays J Clin Microbiol 47 7 Jul 2009 2106 2113
25. B. Schopp, B. Holz, M. Zago, F. Stubenrauch, K.U. Petry, and S.K. Kjaer Evaluation of the performance of the novel PapilloCheck HPV genotyping test by comparison with two other genotyping systems and the HC2 test J Med Virol 82 4 Apr 2010 605 615
26. C.E. Schmeink, W.J. Melchers, A.G. Siebers, W.G. Quint, L.F. Massuger, and R.L. Bekkers Human papillomavirus persistence in young unscreened women, a prospective cohort study PLoS One 6 11 2011 e27937
27. X. Castellsague, and N. Munoz Chapter 3: cofactors in human papillomavirus carcinogenesis-role of parity, oral contraceptives, and tobacco smoking J Natl Cancer Inst Monogr 31 2003 20 28
28. P. Appleby, V. Beral, G.A. Berrington de, D. Colin, S. Franceschi, and A. Goodhill Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies Lancet 370 9599 Nov 10 2007 1609 1621
29. A. Nielsen, T. Iftner, C. Munk, and S.K. Kjaer Acquisition of high-risk human papillomavirus infection in a population-based cohort of Danish women Sex Transm Dis 36 10 Oct 2009 609 615
30. A.T. Lorincz, P.E. Castle, M.E. Sherman, D.R. Scott, A.G. Glass, and S. Wacholder Viral load of human papillomavirus and risk of CIN3 or cervical cancer Lancet 360 9328 Jul 20 2002 228 229
31. A.M. Josefsson, P.K. Magnusson, N. Ylitalo, P. Sorensen, P. Qwarforth-Tubbin, and P.K. Andersen Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study Lancet 355 9222 Jun 24 2000 2189 2193
32. N. Ylitalo, P. Sorensen, A.M. Josefsson, P.K. Magnusson, P.K. Andersen, and J. Ponten Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study Lancet 355 9222 Jun 24 2000 2194 2198
33. I. Alonso, A. Torne, L.M. Puig-Tintore, R. Esteve, L. Quinto, and E. Campo Pre-and post-conization high-risk HPV testing predicts residual/recurrent disease in patients treated for CIN 2-3 Gynecol Oncol 103 2 Nov 2006 631 636
34. J.H. Bae, C.J. Kim, T.C. Park, S.E. Namkoong, and J.S. Park Persistence of human papillomavirus as a predictor for treatment failure after loop electrosurgical excision procedure Int J Gynecol Cancer 17 6 Nov 2007 1271 1277
35. S.M. Kulmala, I.P. Shabalova, N. Petrovitchev, K.J. Syrjanen, U.B. Gyllensten, and B.C. Johansson Type-specific persistence of high-risk human papillomavirus infections in the New Independent States of the former Soviet Union Cohort Study Cancer Epidemiol Biomarkers Prev 16 1 Jan 2007 17 22
36. D.M. van, P.J. Snijders, H.F. Schrijnemakers, F.J. Voorhorst, L. Rozendaal, and M.A. Nobbenhuis Human papillomavirus 16 load in normal and abnormal cervical scrapes: an indicator of CIN II/III and viral clearance Int J Cancer 98 4 Apr 1 2002 590 595
37. N. Munoz, G. Hernandez-Suarez, F. Mendez, M. Molano, H. Posso, and V. Moreno Persistence of HPV infection and risk of high-grade cervical intraepithelial neoplasia in a cohort of Colombian women Br J Cancer 100 7 Apr 7 2009 1184 1190